Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Lundbeck acquires exclusive rights to KW-6356 from Kyowa Hakko Kirin

Oct. 6, 2010

Cortex Pharma regains rights to Ampakine agents for depression and schizophrenia

Oct. 5, 2010

Argenta and Janssen enter into cancer drug discovery agreement

Oct. 5, 2010

Eisai and Anaeropharma partner to discover Bifidobacterium-delivered anticancer agents

Oct. 5, 2010

Global marketing rights to Caelyx to transition from Merck & Co. to Janssen

Oct. 5, 2010

Dyax and CMIC partner in development and marketing of DX-88 for HAE in Japan

Oct. 4, 2010

Aveo Pharmaceuticals regains worldwide rights to AV-299

Oct. 4, 2010

Pieris, sanofi-aventis and Sanofi Pasteur to develop anticalin therapeutics

Oct. 1, 2010

Astellas and UMN Pharma enter definitive agreement for flu vaccines

Oct. 1, 2010

Dana-Farber Cancer Institute and sanofi-aventis collaborate on oncology targets

Sep. 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...